These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15780824)

  • 1. Hypercoagulability in the metabolic syndrome.
    Nieuwdorp M; Stroes ES; Meijers JC; Büller H
    Curr Opin Pharmacol; 2005 Apr; 5(2):155-9. PubMed ID: 15780824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metabolic syndrome as a risk factor for venous and arterial thrombosis.
    Dentali F; Squizzato A; Ageno W
    Semin Thromb Hemost; 2009 Jul; 35(5):451-7. PubMed ID: 19739035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome, haemostasis and thrombosis.
    Alessi MC; Juhan-Vague I
    Thromb Haemost; 2008 Jun; 99(6):995-1000. PubMed ID: 18521499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central obesity, the metabolic syndrome, and plasminogen activator inhibitor-1 in young adults.
    Appel SJ; Harrell JS; Davenport ML
    J Am Acad Nurse Pract; 2005 Dec; 17(12):535-41. PubMed ID: 16293162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between insulin resistance and some coagulation and fibrinolytic parameters in patients with metabolic syndrome.
    Ragab A; Abousamra NK; Higazy A; Saleh O
    Lab Hematol; 2008; 14(1):1-6. PubMed ID: 18403313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemostasis alterations in metabolic syndrome (review).
    Palomo I; Alarcón M; Moore-Carrasco R; Argilés JM
    Int J Mol Med; 2006 Nov; 18(5):969-74. PubMed ID: 17016629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
    Reaven GM
    Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory markers of hypercoagulability.
    Rossi ML; Merlini PA; Ardissino D
    Ital Heart J; 2001 Jul; 2(7):490-4. PubMed ID: 11501955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management issues in the metabolic syndrome.
    Deedwania PC; Gupta R
    J Assoc Physicians India; 2006 Oct; 54():797-810. PubMed ID: 17214277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimarker approach to evaluate the incidence of the metabolic syndrome and longitudinal changes in metabolic risk factors: the Framingham Offspring Study.
    Ingelsson E; Pencina MJ; Tofler GH; Benjamin EJ; Lanier KJ; Jacques PF; Fox CS; Meigs JB; Levy D; Larson MG; Selhub J; D'Agostino RB; Wang TJ; Vasan RS
    Circulation; 2007 Aug; 116(9):984-92. PubMed ID: 17698726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venous thromboembolism in association with features of the metabolic syndrome.
    Ray JG; Lonn E; Yi Q; Rathe A; Sheridan P; Kearon C; ; Yusuf S; Arnold MJ; McQueen MJ; Pogue J; Probstfield J; Fodor G; Held C; Micks M; Genest J
    QJM; 2007 Nov; 100(11):679-84. PubMed ID: 17846056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A metabolic syndrome independent association between overweight, fibrinolysis impairment and low-grade inflammation in young women with venous thromboembolism.
    Salobir B; Sabovic M
    Blood Coagul Fibrinolysis; 2006 Oct; 17(7):551-6. PubMed ID: 16988550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene polymorphisms implicated in influencing susceptibility to venous and arterial thromboembolism: frequency distribution in a healthy German population.
    Hoppe B; Tolou F; Dörner T; Kiesewetter H; Salama A
    Thromb Haemost; 2006 Oct; 96(4):465-70. PubMed ID: 17003923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The metabolic syndrome and cardiovascular disease.
    Bonora E
    Ann Med; 2006; 38(1):64-80. PubMed ID: 16448990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Markers of pro-inflammatory and pro-thrombotic state in the diagnosis of metabolic syndrome.
    Odrowaz-Sypniewska G
    Adv Med Sci; 2007; 52():246-50. PubMed ID: 18217426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of postprandial hyperglycemia by acarbose is a promising therapeutic strategy for the treatment of patients with the metabolic syndrome.
    Yamagishi S; Nakamura K; Takeuchi M
    Med Hypotheses; 2005; 65(1):152-4. PubMed ID: 15893133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonalcoholic fatty liver disease as a contributor to hypercoagulation and thrombophilia in the metabolic syndrome.
    Targher G; Chonchol M; Miele L; Zoppini G; Pichiri I; Muggeo M
    Semin Thromb Hemost; 2009 Apr; 35(3):277-87. PubMed ID: 19452403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The metabolic syndrome and the risk of arterial and venous thrombosis.
    Franchini M; Targher G; Montagnana M; Lippi G
    Thromb Res; 2008; 122(6):727-35. PubMed ID: 17996282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms for vascular injury in the metabolic syndrome.
    Yamagishi S; Nakamura K; Jinnouchi Y; Takenaka K; Imaizumi T
    Drugs Exp Clin Res; 2005; 31(3):123-9. PubMed ID: 16033251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.